9 results on '"Tucker, Joseph D."'
Search Results
2. Improving cascade outcomes for active TB: A global systematic review and meta-analysis of TB interventions.
- Author
-
Marley, Gifty, Zou, Xia, Nie, Juan, Cheng, Weibin, Xie, Yewei, Liao, Huipeng, Wang, Yehua, Tao, Yusha, Tucker, Joseph D., Sylvia, Sean, Chou, Roger, Wu, Dan, Ong, Jason, and Tang, Weiming
- Subjects
- *
DIRECTLY observed therapy , *TUBERCULOSIS , *RANDOM effects model , *EDUCATIONAL outcomes , *CINAHL database - Abstract
Background: To inform policy and implementation that can enhance prevention and improve tuberculosis (TB) care cascade outcomes, this review aimed to summarize the impact of various interventions on care cascade outcomes for active TB. Methods and findings: In this systematic review and meta-analysis, we retrieved English articles with comparator arms (like randomized controlled trials (RCTs) and before and after intervention studies) that evaluated TB interventions published from January 1970 to September 30, 2022, from Embase, CINAHL, PubMed, and the Cochrane library. Commentaries, qualitative studies, conference abstracts, studies without standard of care comparator arms, and studies that did not report quantitative results for TB care cascade outcomes were excluded. Data from studies with similar comparator arms were pooled in a random effects model, and outcomes were reported as odds ratio (OR) with 95% confidence interval (CI) and number of studies (k). The quality of evidence was appraised using GRADE, and the study was registered on PROSPERO (CRD42018103331). Of 21,548 deduplicated studies, 144 eligible studies were included. Of 144 studies, 128 were from low/middle-income countries, 84 were RCTs, and 25 integrated TB and HIV care. Counselling and education was significantly associated with testing (OR = 8.82, 95% CI:1.71 to 45.43; I2 = 99.9%, k = 7), diagnosis (OR = 1.44, 95% CI:1.08 to 1.92; I2 = 97.6%, k = 9), linkage to care (OR = 3.10, 95% CI = 1.97 to 4.86; I2 = 0%, k = 1), cure (OR = 2.08, 95% CI:1.11 to 3.88; I2 = 76.7%, k = 4), treatment completion (OR = 1.48, 95% CI: 1.07 to 2.03; I2 = 73.1%, k = 8), and treatment success (OR = 3.24, 95% CI: 1.88 to 5.55; I2 = 75.9%, k = 5) outcomes compared to standard-of-care. Incentives, multisector collaborations, and community-based interventions were associated with at least three TB care cascade outcomes; digital interventions and mixed interventions were associated with an increased likelihood of two cascade outcomes each. These findings remained salient when studies were limited to RCTs only. Also, our study does not cover the entire care cascade as we did not measure gaps in pre-testing, pretreatment, and post-treatment outcomes (like loss to follow-up and TB recurrence). Conclusions: Among TB interventions, education and counseling, incentives, community-based interventions, and mixed interventions were associated with multiple active TB care cascade outcomes. However, cost-effectiveness and local-setting contexts should be considered when choosing such strategies due to their high heterogeneity. Author summary: Why was this study done?: Developing new and innovative interventions to improve tuberculosis (TB) care services use and successful treatment are essential to the global efforts to end TB. There is a limited scope on the overall impact of these interventions because most studies focus on interventions' capacity to enhance specific TB care outcomes. Evaluating existing evidence to ascertain the effect TB interventions on overall care cascade outcomes is paramount to informing holistic TB control strategies What did the researchers do and find?: We systematically reviewed and meta-analyzed evidence on TB interventions and their effects on the TB care cascade for active TB from 144 peer-reviewed studies. In this study, the 5 out of 12 identified TB interventions associated with multiple care cascade outcomes were education and counseling, incentives, digital interventions, community-based, multisector collaborations, and mixed interventions. Among LMIC studies, education and counseling, incentives, community-based interventions, and multisector collaborations were the interventions associated with at least three TB care cascade outcomes. What do these findings mean?: A wide range of relatively simple interventions could substantially improve TB care outcomes. Multistep efficient interventions like education and counseling, incentives, and mixed interventions should be keenly considered in expanding active TB control programs. Researchers should revise multistage effective interventions to incorporate local context needs due to their high heterogeneity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial.
- Author
-
Wang, Cheng, Ong, Jason J., Zhao, Peizhen, Weideman, Ann Marie, Tang, Weiming, Smith, M. Kumi, Marks, Michael, Fu, Hongyun, Cheng, Weibin, Terris-Prestholt, Fern, Zheng, Heping, Tucker, Joseph D., and Yang, Bin
- Subjects
- *
RANDOMIZED controlled trials , *SYPHILIS , *PATIENT self-monitoring , *PRE-exposure prophylaxis , *COVID-19 , *MEN who have sex with men , *HIV testing kits - Abstract
Background: Low syphilis testing uptake is a major public health issue among men who have sex with men (MSM) in many low- and middle-income countries. Syphilis self-testing (SST) may complement and extend facility-based testing. We aimed to evaluate the effectiveness and costs of providing SST on increasing syphilis testing uptake among MSM in China.Methods and Findings: An open-label, parallel 3-arm randomized controlled trial (RCT) was conducted between January 7, 2020 and July 17, 2020. Men who were at least 18 years of age, had condomless anal sex with men in the past year, reported not testing for syphilis in the last 6 months, and had a stable residence with mailing addresses were recruited from 124 cities in 26 Chinese provinces. Using block randomization with blocks of size 12, enrolled participants were randomly assigned (1:1:1) into 3 arms: standard of care arm, standard SST arm, and lottery incentivized SST arm (1 in 10 chance to win US$15 if they had a syphilis test). The primary outcome was the proportion of participants who tested for syphilis during the trial period and confirmed with photo verification and between arm comparisons were estimated with risk differences (RDs). Analyses were performed on a modified intention-to-treat basis: Participants were included in the complete case analysis if they had initiated at least 1 follow-up survey. The Syphilis/HIV Duo rapid test kit was used. A total of 451 men were enrolled. In total, 136 (90·7%, 136/150) in the standard of care arm, 142 (94·0%, 142/151) in the standard of SST arm, and 137 (91·3%, 137/150) in the lottery incentivized SST arm were included in the final analysis. The proportion of men who had at least 1 syphilis test during the trial period was 63.4% (95% confidence interval [CI]: 55.5% to 71.3%, p = 0.001) in the standard SST arm, 65.7% (95% CI: 57.7% to 73.6%, p = 0.0002) in the lottery incentivized SST arm, and 14.7% (95% CI: 8.8% to 20.7%, p < 0.001) in the standard of care arm. The estimated RD between the standard SST and standard of care arm was 48.7% (95% CI: 37.8% to 58.4%, p < 0.001). The majority (78.5%, 95% CI: 72.7% to 84.4%, p < 0.001) of syphilis self-testers reported never testing for syphilis. The cost per person tested was US$26.55 for standard SST, US$28.09 for the lottery incentivized SST, and US$66.19 for the standard of care. No study-related adverse events were reported during the study duration. Limitation was that the impact of the Coronavirus Disease 2019 (COVID-19) restrictions may have accentuated demand for decentralized testing.Conclusions: Compared to standard of care, providing SST significantly increased the proportion of MSM testing for syphilis in China and was cheaper (per person tested).Trial Registration: Chinese Clinical Trial Registry: ChiCTR1900022409. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
4. Monetary incentives and peer referral in promoting secondary distribution of HIV self-testing among men who have sex with men in China: A randomized controlled trial.
- Author
-
Zhou, Yi, Lu, Ying, Ni, Yuxin, Wu, Dan, He, Xi, Ong, Jason J., Tucker, Joseph D., Sylvia, Sean Y., Jing, Fengshi, Li, Xiaofeng, Huang, Shanzi, Shen, Guangquan, Xu, Chen, Xiong, Yuan, Sha, Yongjie, Cheng, Mengyuan, Xu, Junjie, Jiang, Hongbo, Dai, Wencan, and Huang, Liqun
- Subjects
- *
MONETARY incentives , *PATIENT self-monitoring , *RANDOMIZED controlled trials , *COVID-19 , *MEN who have sex with men , *PRE-exposure prophylaxis - Abstract
Background: Digital network-based methods may enhance peer distribution of HIV self-testing (HIVST) kits, but interventions that can optimize this approach are needed. We aimed to assess whether monetary incentives and peer referral could improve a secondary distribution program for HIVST among men who have sex with men (MSM) in China.Methods and Findings: Between October 21, 2019 and September 14, 2020, a 3-arm randomized controlled, single-blinded trial was conducted online among 309 individuals (defined as index participants) who were assigned male at birth, aged 18 years or older, ever had male-to-male sex, willing to order HIVST kits online, and consented to take surveys online. We randomly assigned index participants into one of the 3 arms: (1) standard secondary distribution (control) group (n = 102); (2) secondary distribution with monetary incentives (SD-M) group (n = 103); and (3) secondary distribution with monetary incentives plus peer referral (SD-M-PR) group (n = 104). Index participants in 3 groups were encouraged to order HIVST kits online and distribute to members within their social networks. Members who received kits directly from index participants or through peer referral links from index MSM were defined as alters. Index participants in the 2 intervention groups could receive a fixed incentive ($3 USD) online for the verified test result uploaded to the digital platform by each unique alter. Index participants in the SD-M-PR group could additionally have a personalized peer referral link for alters to order kits online. Both index participants and alters needed to pay a refundable deposit ($15 USD) for ordering a kit. All index participants were assigned an online 3-month follow-up survey after ordering kits. The primary outcomes were the mean number of alters motivated by index participants in each arm and the mean number of newly tested alters motivated by index participants in each arm. These were assessed using zero-inflated negative binomial regression to determine the group differences in the mean number of alters and the mean number of newly tested alters motivated by index participants. Analyses were performed on an intention-to-treat basis. We also conducted an economic evaluation using microcosting from a health provider perspective with a 3-month time horizon. The mean number of unique tested alters motivated by index participants was 0.57 ± 0.96 (mean ± standard deviation [SD]) in the control group, compared with 0.98 ± 1.38 in the SD-M group (mean difference [MD] = 0.41),and 1.78 ± 2.05 in the SD-M-PR group (MD = 1.21). The mean number of newly tested alters motivated by index participants was 0.16 ± 0.39 (mean ± SD) in the control group, compared with 0.41 ± 0.73 in the SD-M group (MD = 0.25) and 0.57 ± 0.91 in the SD-M-PR group (MD = 0.41), respectively. Results indicated that index participants in intervention arms were more likely to motivate unique tested alters (control versus SD-M: incidence rate ratio [IRR = 2.98, 95% CI = 1.82 to 4.89, p-value < 0.001; control versus SD-M-PR: IRR = 3.26, 95% CI = 2.29 to 4.63, p-value < 0.001) and newly tested alters (control versus SD-M: IRR = 4.22, 95% CI = 1.93 to 9.23, p-value < 0.001; control versus SD-M-PR: IRR = 3.49, 95% CI = 1.92 to 6.37, p-value < 0.001) to conduct HIVST. The proportion of newly tested testers among alters was 28% in the control group, 42% in the SD-M group, and 32% in the SD-M-PR group. A total of 18 testers (3 index participants and 15 alters) tested as HIV positive, and the HIV reactive rates for alters were similar between the 3 groups. The total costs were $19,485.97 for 794 testers, including 450 index participants and 344 alter testers. Overall, the average cost per tester was $24.54, and the average cost per alter tester was $56.65. Monetary incentives alone (SD-M group) were more cost-effective than monetary incentives with peer referral (SD-M-PR group) on average in terms of alters tested and newly tested alters, despite SD-M-PR having larger effects. Compared to the control group, the cost for one more alter tester in the SD-M group was $14.90 and $16.61 in the SD-M-PR group. For newly tested alters, the cost of one more alter in the SD-M group was $24.65 and $49.07 in the SD-M-PR group. No study-related adverse events were reported during the study. Limitations include the digital network approach might neglect individuals who lack internet access.Conclusions: Monetary incentives alone and the combined intervention of monetary incentives and peer referral can promote the secondary distribution of HIVST among MSM. Monetary incentives can also expand HIV testing by encouraging first-time testing through secondary distribution by MSM. This social network-based digital approach can be expanded to other public health research, especially in the era of the Coronavirus Disease 2019 (COVID-19).Trial Registration: Chinese Clinical Trial Registry (ChiCTR) ChiCTR1900025433. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
5. Social Innovation For Health Research: Development of the SIFHR Checklist.
- Author
-
Kpokiri, Eneyi E., Chen, Elizabeth, Li, Jingjing, Payne, Sarah, Shrestha, Priyanka, Afsana, Kaosar, Amazigo, Uche, Awor, Phyllis, de Lavison, Jean-Francois, Khan, Saqif, Mier-Alpaño, Jana, Ong Jr, Alberto, Subhedar, Shivani, Wachmuth, Isabelle, Cuervo, Luis Gabriel, Mehta, Kala M., Halpaap, Beatrice, Tucker, Joseph D., and Ong, Alberto Jr
- Subjects
- *
SOCIAL innovation , *PUBLIC health research , *INTERNET access , *RESEARCH methodology , *SOCIAL background - Abstract
Background: Social innovations in health are inclusive solutions to address the healthcare delivery gap that meet the needs of end users through a multi-stakeholder, community-engaged process. While social innovations for health have shown promise in closing the healthcare delivery gap, more research is needed to evaluate, scale up, and sustain social innovation. Research checklists can standardize and improve reporting of research findings, promote transparency, and increase replicability of study results and findings.Methods and Findings: The research checklist was developed through a 3-step community-engaged process, including a global open call for ideas, a scoping review, and a 3-round modified Delphi process. The call for entries solicited checklists and related items and was open between November 27, 2019 and February 1, 2020. In addition to the open call submissions and scoping review findings, a 17-item Social Innovation For Health Research (SIFHR) Checklist was developed based on the Template for Intervention Description and Replication (TIDieR) Checklist. The checklist was then refined during 3 rounds of Delphi surveys conducted between May and June 2020. The resulting checklist will facilitate more complete and transparent reporting, increase end-user engagement, and help assess social innovation projects. A limitation of the open call was requiring internet access, which likely discouraged participation of some subgroups.Conclusions: The SIFHR Checklist will strengthen the reporting of social innovation for health research studies. More research is needed on social innovation for health. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
6. How to make your research jump off the page: Co-creation to broaden public engagement in medical research.
- Author
-
Finley, Nina, Swartz, Talia H., Cao, Kevin, and Tucker, Joseph D.
- Subjects
- *
MEDICAL research , *AUTHORSHIP collaboration - Abstract
Nina Finley and co-authors discuss public involvement in planning and reporting medical research. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
7. Correction: Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial.
- Author
-
Wang, Cheng, Ong, Jason J., Zhao, Peizhen, Weideman, Ann Marie, Tang, Weiming, Smith, M. Kumi, Marks, Michael, Fu, Hongyun, Cheng, Weibin, Terris-Prestholt, Fern, Zheng, Heping, Tucker, Joseph D., and Yang, Bin
- Subjects
- *
PATIENT self-monitoring , *RANDOMIZED controlled trials , *SYPHILIS , *CONDOMS , *SEXUALLY transmitted diseases - Abstract
Graph Table 4 HIV/STI testing and sexual behaviors self-reported by men who had syphilis testing during the trial and initiated at least 1 follow-up survey. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
8. Research on HIV cure: Mapping the ethics landscape.
- Author
-
Dubé, Karine, Sylla, Laurie, Dee, Lynda, Taylor, Jeff, Evans, David, Bruton, Carl Dean, Gilberston, Adam, Gralinski, Lisa, Brown, Brandon, Skinner, Asheley, Weiner, Bryan J., Greene, Sandra B., Corneli, Amy, Adimora, Adaora A., Tucker, Joseph D., and Rennie, Stuart
- Subjects
- *
THERAPEUTICS , *HIV-positive persons , *HIV infections , *HIV , *AIDS patients , *DIAGNOSIS of HIV infections , *HIV infection epidemiology , *ANIMALS , *BIOLOGICAL models , *COST effectiveness , *DIFFUSION of innovations , *FORECASTING , *HEALTH services accessibility , *IMMUNITY , *MEDICAL care costs , *MEDICAL research , *TREATMENT effectiveness , *ECONOMICS - Abstract
In an essay, Karine Dubé and coauthors discuss the ethics of preclinical and clinical studies relevant to achieving an HIV cure. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
9. Correction: Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial.
- Author
-
Wang, Cheng, Ong, Jason J, Zhao, Peizhen, Weideman, Ann Marie, Tang, Weiming, Smith, M Kumi, Marks, Michael, Fu, Hongyun, Cheng, Weibin, Terris-Prestholt, Fern, Zheng, Heping, Tucker, Joseph D, and Yang, Bin
- Abstract
[This corrects the article DOI: 10.1371/journal.pmed.1003930.]. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.